Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
Methotrexate
•
General Rheumatology
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Related Questions
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
Can lupus anticoagulant be positive despite a normal aPTT?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
Does the pattern on chest CT help determine which patients with RA-ILD will respond to immunosuppression?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
